( SEVAMED 2003)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,  Vaccines & Drugs)

Click Here for Abstract

Back To Content Page

January 2003 

6063.         Agarwal N, Handa R, Acharya S K, Wali J P, Dinda A K, Aggarwal P. Study of autoimmune markers in hepatitis C infection. Indian J med Res 2001; 17(2), 132-40.

6064.         Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. J Med Microbiol. 2002 Aug;51(8):700-4.

6065.         Choudhury N, Phadke S. Transfusion transmitted disease. Indian J Pediat 2001; 68(10), 951-8.

6066.         Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002 Aug;36(2):479-97.

6067.         Giachetti C, Linnen JM, Kolk DP, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick MK, Mimms LT, McDonough SH. Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol. 2002 Jul;40(7):2408-19.

6068.         Kalamvoki M, Miriagou V, Hadziyannis A, Georgopoulou U, Varaklioti A, Hadziyannis S, Mavromara P. Expression of immunoreactive forms of the hepatitis C NS5A protein in E. coli and their use for diagnostic assays. Arch Virol. 2002 Sep;147(9):1733-45.

6069.         Khosla S, Ballard FJ, Conover CA. Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis. J Clin Endocrinol Metab. 2002 Aug;87(8):3867-70.

6070.         Osiowy C. Sensitive detection of HBsAg mutants by a gap ligase chain reaction assay. J Clin Microbiol. 2002 Jul;40(7):2566-71.

6071.         Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, Heathcote EJ, Brown NA, Atkins M, Woessner M, Gardner SD. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology. 2002 Jul;36(1):186-94.

6072.         Sarman Singh, Mohanty A, Joshi Y K, Dwivedi S N, Deka D. Outcome of hepatitis E virus infection in Indian pregnant women admitted to a tertiary care hospital. Indian J med Res.2001; 113(Feb), 35-9.

6073.         Shibolet O, Ilan Y, Gillis S, Hubert A, Shouval D, Safadi R. Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. Blood. 2002 Jul 15;100(2):391-6.


6075.         Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC.  Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. J Virol. 2002 Aug;76(16):8148-60.

6076.         Barcena Marugan R, Garcia-Hoz F, Vazquez Romero M, Nash R, Mateos M, Gonzalez Alonso R, Garcia Gonzalez M, Garcia Plaza A. Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination. Am J Gastroenterol. 2002 Sep;97(9):2398-401.

6077.         Bouvier-Alias M, Patel K, Dahari H, Beaucourt S, Larderie P, Blatt L, Hezode C, Picchio G, Dhumeaux D, Neumann AU, McHutchison JG, Pawlotsky JM. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology. 2002 Jul;36(1):211-8.

6078.         Cook IF, Murtagh J. Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants. J Paediatr Child Health. 2002 Aug;38(4):393-6.

6079.         Hohn H, Neukirch C, Freitag K, Necker A, Hitzler W, Seliger B, Maeurer MJ. Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen. Clin Exp Immunol. 2002 Aug;129(2):309-17.

6080.         Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM.  Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol. 2002 Jul;76(13):6586-95.

6081.         Nyamathi A, Robbins WA, Fahey JL, Wiley D, Pekler VA, Longshore D, Robins TA, Singh J, Saab S. Presence and predictors of hepatitis C virus RNA in the semen of homeless men. Biol Res Nurs. 2002 Jul;4(1):22-30.

6082.         Rapicetta M, Ferrari C, Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol. 2002 Jul;67(3):454-7. Review.

6083.         Woitas RP, Sippel M, Althausen EM, Brackmann HH, Kochan B, Matz B, Rockstroh JK, Sauerbruch T, Spengler U. Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection. Immunology. 2002 Jul;106(3):419-27.


6084.         Mele A, Stroffolini T, Zanetti AR. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination. J Med Virol. 2002 Jul;67(3):440-3. Review.

6085.         Seto D, West DJ, Ioli VA. Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J. 2002 Aug;21(8):793-5.


6086.         Starkel P, Cicarelli O, Lerut J, Goubau P, Rahier J, Horsmans Y. Limited lamivudine and long-term hepatitis B immunoglobulin immunoprophylaxis for prevention of hepatitis B recurrence after liver transplantation. Transplantation. 2002 Aug 15;74(3):408-10.

April 2003 

  1. Alberti A, Noventa F, Benvegnu L, Boccato S, Gatta A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection.Ann Intern Med. 2002 Dec 17;137(12):961-4.

  2. Apolinario A, Majano PL, Alvarez-Perez E, Saez A, Lozano C, Vargas J, Garcia Monzon C. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol. 2002 Nov;97(11):2861-70.

  3. Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y.  Human parvovirus B19 infection in children: uncommon clinical presentations. Isr Med Assoc J. 2002 Oct;4(10):763-5.

  4. Bergamini A, Cepparulo M, Bolacchi F, Araco A, Tisone G, Ombres D, Rocchi G, Angelico M. Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo.Clin Exp Immunol. 2002 Nov;130(2):293-9.

  5. Boyle BA. Recent research in HIV infection, part 2. AIDS Read. 2002 Dec;12(12):524-6, 539.

  6. Chang YC, Ho CL, Chen HH, Chang TT, Lai WW, Dai YC, Lee WY, Chow NH. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.Br J Cancer. 2002 Dec 2;87(12):1449-53.

  7. Clark CH, Mahoney JS, Clark DJ, Eriksen LR. Screening for depression in a hepatitis C population: the reliability and validity of the Center for Epidemiologic Studies Depression Scale (CES-D).J Adv Nurs. 2002 Nov;40(3):361-9.

  8. Davis GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S145-51.

  9. Di Martino V, Thevenot T, Colin JF, Boyer N, Martinot M, Degos F, Coulaud JP, Vilde JL, Vachon F, Degott C, Valla D, Marcellin P.  Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.Gastroenterology. 2002 Dec;123(6):1812-22.

  10. Diment J, Calmann M. Alternatives to nucleic acid testing in the blood transfusion service.Lancet. 2002 Nov 9;360(9344):1518-9; author reply 1519-20.

  11. Edlin BR. Prevention and treatment of hepatitis C in injection drug users. Hepatology. 2002 Nov;36(5 Suppl 1):S210-9.

  12. Fleming J. Current treatments for hepatitis. J Infus Nurs. 2002 Nov-Dec;25(6):379-82.

  13. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S57-64.

  14. Forns X, Ampurdanes S, Llovet JM,Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002 Oct;36(4 Pt 1):986-92.

  15. Hagan H, Thiede H, McGough JP, Alexander ER. Hepatitis B vaccination among research participants, Seattle, Washington. Am J Public Health. 2002 Nov;92(11):1756.

  16. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002 Nov;36(5):1206-13.

  17. Izumi Y, Kaneko A, Oku K, Kimura M, Tanaka S, Tada H, Tatsumi K, Takano T, Hidaka Y, Amino N. Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases. J Intern Med. 2002 Oct;252(4):361-7.

  18. Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. Gastroenterology. 2002 Oct;123(4):1070-83.

  19. Kanno A, Kazuyama Y. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J Med Virol. 2002 Oct;68(2):229-33.

  20. Kawai S, Yokosuka O, Imazeki F, Saisho H, Mizuno C. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level. J Med Virol. 2002 Nov;68(3):343-51.

  21. Kobayashi T, Sugawara Y, Shi YZ, Makuuchi M. Telomerase expression and p53 status in hepatocellular carcinoma. Am J Gastroenterol. 2002 Dec;97(12):3166-71.

  22. Kuehne FC, Bethe U, Freedberg K, Goldie SJ. Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness. Arch Intern Med. 2002 Dec 9-23;162(22):2545-56.

  23. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, Spengler U.  Imbalanced intrahepatic expression of interleukin 12, interferon gamma, and interleukin 10 in fulminant hepatitis B. Hepatology. 2002 Oct;36(4 Pt 1):1001-8.

  24. Marcellin P, Asselah T, Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S47-56.

  25. Mazziotti G, Sorvillo F, Morisco F, Carbone A, Rotondi M, Stornaiuolo G, Precone DF, Cioffi M, Gaeta GB, Caporaso N, Carella C.  Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. Cancer. 2002 Dec 15;95(12):2539-45.

  26. McCulloch M, Broffman M, Gao J, Colford JM Jr. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials. Am J Public Health. 2002 Oct;92(10):1619-28.

  27. Menon Y, Singh R, Cuchacovich R, Espinoza LR. Pulmonary involvement in hepatitis B-related polyarteritis nodosa. Chest. 2002 Oct;122(4):1497-8.

  28. Nikolova M, Liubomirova M, Iliev A, Krasteva R, Andreev E, Radenkova J, Minkova V, Djerassi R, Kiperova B, Vlahov ID.  Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers. Isr Med Assoc J. 2002 Nov;4(11 Suppl):908-10.

  29. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.Ann Intern Med. 2002 Dec 17;137(12):947-54.

  30. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002 Nov;36(5 Suppl 1):S65-73.

  31. Pol S, Lebray P.N-acetylcysteine for paracetamol poisoning: effect on prothrombin. Lancet. 2002 Oct 12;360(9340):1115.

  32. Pradat P, Alberti A, Poynard T, Esteban JI, Weiland O, Marcellin P, Badalamenti S, Trepo C.  Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology. 2002 Oct;36(4 Pt 1):973-7.

  33. Prokurat A, Kluge P, Chrupek M, Kosciesza A, Rajszys P. Hemangioma of the liver in children: proliferating vascular tumor or congenital vascular malformation? Med Pediatr Oncol. 2002 Nov;39(5):524-9.

  34. Renou C, Pol S, Halfon P, Caillat-Zucman S. Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? Gastroenterology. 2002 Nov;123(5):1748-9

  35. Requena-Silla Y, Rosenfield CG, Miller LC.  Antiphospholipid antibodies and Down syndrome: a case series. J Pediatr Hematol Oncol. 2002 Oct;24(7):575-8.

Pathogenesis :

  1. Agnello V, Mecucci C, Casato M. Regression of splenic lymphoma after treatment of hepatitis C virus infection.N Engl J Med. 2002 Dec 26;347(26):2168-70

  2. Buendia MA. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol. 2002 Nov;39(5):530-5.

  3. Cainelli F, Vento S.  Sequelae and serologic outcome in persons with hepatitis B virus infection. Ann Intern Med. 2002 Oct 1;137(7):619

  4. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C, Hong Z, Lau JY, Tam RC. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons.J Virol. 2002 Nov;76(21):11148-54.

  5. Cooper CL, Cameron DW. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis. 2002 Oct 1;35(7):873-9.

  6. Diamond C, Lee JH. Use of antiviral therapy in patients with hepatitis C. Ann Intern Med. 2002 Dec 17;137(12):1012.

  7. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ. Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):536-41.

  8. Guida M, D'Elia G, Benvestito S, Casamassima A, Micelli G, Quaranta M, Moschetta R, De Lena M, Lorusso V. Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders.Leukemia. 2002 Oct;16(10):2162-3.

  9. Halkic N, Bally F, Gillet M. Organ transplantation in HIV-infected patients. N Engl J Med. 2002 Nov 28;347(22):1801-3

  10. Hofer H, Bankl HC, Wrba F, Steindl-Munda P, Peck-Radosavljevic M, Osterreicher C, Mueller C, Gangl A, Ferenci P.  Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol. 2002 Nov;97(11):2880-5.

  11. Huang JW, Yen CJ, Pai MF, Wu KD, Tsai TJ, Hsieh BS. Association between serum aspartate transaminase and homocysteine levels in hemodialysis patients.Am J Kidney Dis. 2002 Dec;40(6):1195-201.

  12. Jacobs RJ, Meyerhoff AS, Koff RS. Re: Arguedas et al.--Hepatitis A prevention analysis.Am J Gastroenterol. 2002 Nov;97(11):2924-5

  13. Johnson B.Hepatitis C: be positively aware of the risk of transmission and treatment. Posit Aware. 2002 Nov-Dec;13(6):29-31.

  14. Labonte P, Axelrod V, Agarwal A, Aulabaugh A, Amin A, Mak P. Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis. J Biol Chem. 2002 Oct 11;277(41):38838-46.

  15. Loustaud-Ratti V, Liozon E, Karaaslan H, Alain S, Paraf F, Le Meur Y, Denis F, Vidal E.Interferon alpha and ribavirin for membranoproliferative glomerulonephritis and hepatitis C infection. Am J Med. 2002 Oct 15;113(6):516-9.

  16. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002 Oct;17(10):1049-55.

  17. Osawa Y, Nagaki M, Banno Y, Brenner DA, Asano T, Nozawa Y, Moriwaki H, Nakashima S. Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes. Infect Immun. 2002 Nov;70(11):6294-301.

  18. Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of five cases.Dig Dis Sci. 2002 Dec;47(12):2664-8.

  19. Qian GS, Kuang SY, He X, Groopman JD, Jackson PE. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1126-9.

  20. Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002 Oct 15;35(8):974-81.

  21. Ressel GW.CDC releases 2002 guidelines for treating STDs: Part II. Human papillomavirus and hepatitis. Am Fam Physician. 2002 Nov 15;66(10):1996, 1999.

  22. Rossi A, Renzetti D, D'Albenzio L, Gianfelice D, Kalyvoka A, Rinaldi O. Case of mania induced by withdrawal of interferon-alpha in a patient affected by bipolar disorder. Psychiatry Clin Neurosci. 2002 Dec;56(6):647-8.

  23. Sarrazin C, Herrmann E, Bruch K, Zeuzem S. Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses. J Virol. 2002 Nov;76(21):11079-90.

  24. Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med. 2002 Oct 1;166(7):916-9.

  25. Somjee S, Pai S, Parikh P, Banavali S, Kelkar R, Advani S.  Passive active prophylaxis against Hepatitis B in children with acute lymphoblastic leukemia. Leuk Res. 2002 Nov;26(11):989-92.

  26. Stancu M, Jones D, Vega F, Medeiros LJ.  Peripheral T-cell lymphoma arising in the liver. Am J Clin Pathol. 2002 Oct;118(4):574-81.

  27. Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, Sakuta S.  Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology. 2002 Oct;36(4 Pt 1):1022.

  28. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002 Dec 14;360(9349):1921-6.

  29. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology. 2002 Nov;36(5 Suppl 1):S201-9.

  30. Tiffen L, Sheridan S. Improving take-up of hepatitis C services. Nurs Times. 2002 Oct 22-28;98(43):30-2.

  31. Welch KJ, Morse A. Improving screening and vaccination for hepatitis B in patients coinfected with HIV and hepatitis C. Am J Gastroenterol. 2002 Nov;97(11):2928-9.

  32. Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2002 Oct 21;177(8):440-3.

  33. Wright TL. Treatment of patients with hepatitis C and cirrhosis. Hepatology. 2002 Nov;36(5 Suppl 1):S185-94.

  34. Yao N, Hong Z, Lau JY. Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy. Gastroenterology. 2002 Oct;123(4):1350-63.

  35. Young KC, Lin PW, Hsiao WC, Chang TT, Chang YC, Wu HL. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver. J Med Virol. 2002 Oct;68(2):188-96.

  36. Youssef WI, Tavill AS. Connective tissue diseases and the liver. J Clin Gastroenterol. 2002 Oct;35(4):345-9.

  37. Zhu H, Wang SY, Zhang JY, Lian QZ, Peng XX.  Analysis of complement-bound HCV complexes using a novel immuno-capture RT-PCR method. Scand J Immunol. 2002 Nov;56(5):538-42.

Vaccines :

  1. Lohr HF, Pingel S, Bocher WO, Bernhard H, Herzog-Hauff S, Rose-John S, Galle PR. Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clin Exp Immunol. 2002 Oct;130(1):107-14.

July 2003

7235.   Akuta N, Suzuki F, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H.  Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy. J Med Virol. 2003 Mar;69(3):376-83.

7236.   Alter MJ, Kuhnert WL, Finelli L.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003 Feb 7;52(RR-3):1-13, 15; quiz CE1-4.

7237.   Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.   Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003 Mar;98(3):679-90.

7238.   Bandi L.  Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked. Postgrad Med. 2003 Feb;113(2):73-6, 86.

7239.   Barrett S, Ryan E, Crowe J.  Serum versus intrahepatic HCV RNA and liver histology in anti-HCV-positive serum PCR-negative individuals. Hepatology. 2003 Jan;37(1):223-4.

7240.   Baughman RP, Koehler A, Bejarano PA, Lower EE, Weber FL Jr.  Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med. 2003 Mar 10;163(5):615-20.

7241.   Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S.   Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology. 2003 Mar;37(3):600-9.

7242.   Bortolotti F, Muratori L, Jara P, Hierro L, Verucchi G, Giacchino R, Barbera C, Zancan L, Guido M, Resti M, Pedditzi S, Bianchi F, Gatta A.  Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr. 2003 Feb;142(2):185-90.

7243.   Caturelli E, Castellano L, Fusilli S, Palmentieri B, Niro GA, del Vecchio-Blanco C, Andriulli A, de Sio I.   Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma. Radiology. 2003 Mar;226(3):691-7.

7244.   Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schoniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Muller C, Wrba F, Gangl A, Ferenci P.  Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol. 2003 Feb;98(2):442-7.

7245.   Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW.  Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology. 2003 Mar;37(3):544-50.

7246.   Chiu HF, Chih TT, Hsian YM, Tseng CH, Wu MJ, Wu YC.  Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells. Biochem Pharmacol. 2003 Feb 1;65(3):319-27.

7247.   Daveau M, Scotte M, Francois A, Coulouarn C, Ros G, Tallet Y, Hiron M, Hellot MF, Salier JP.   Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog. 2003 Mar;36(3):130-41.

7248.   De Rosa FG, Bonora S, Di Perri G.  Healthy ranges for alanine aminotransferase levels. Ann Intern Med. 2003 Jan 21;138(2):156-7

7249.   Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB.  Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem. 2003 Mar;49(3):479-86.

7250.   Fabris P, Tositti G, Giordani MT, Romano L, Betterle C, Pignattari E, Tagliaferri C, Muratori P, Manfrin V, de Lalla F. Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus. J Med Virol. 2003 Mar;69(3):339-43.

7251.   Fujita N, Kaito M, Takeo M, Iwasa M, Ikoma J, Watanabe S, Adachi Y. Nonimmune complexed HCV RNA titer in serum as a predictor of interferon response in patients with chronic hepatitis C.Am J Gastroenterol. 2003 Mar;98(3):645-52.

7252.   Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R.  Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.Arch Intern Med. 2003 Jan 27;163(2):218-24.

7253.   Jayshree RS, Sridhar H, Devi GM. Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study. Cancer. 2003 Feb 25;99(1):63-7.

7254.   Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N.   Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in  chronic hepatitis C virus infection. J Immunol. 2003 Feb 1;170(3):1249-56.

7255.   Kien F, Abraham JD, Schuster C, Kieny MP.  Analysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteins. J Gen Virol. 2003 Mar;84(Pt 3):561-6.

7256.   Levine PH, Delgado Y, Theise ND, West AB.  Stellate-cell lipidosis in liver biopsy specimens. Recognition and significance. Am J Clin Pathol. 2003 Feb;119(2):254-8.

7257.   Ma CL, Fang DX, Chen HB, Li FQ, Jin HY, Li SQ, Tan WG.  A mutation specific polymerase chain reaction for detecting hepatitis B virus genome mutations at nt551. World J Gastroenterol. 2003 Mar;9(3):509-12.

7258.   Matsukura S, Soejima H, Nakagawachi T, Yakushiji H, Ogawa A, Fukuhara M, Miyazaki K, Nakabeppu Y, Sekiguchi M, Mukai T.   CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. Br J Cancer. 2003 Feb 24;88(4):521-9.

7259.   Myers RP, De Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T.  Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci. 2003 Jan;48(1):146-53.

7260.   Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G.   Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003 Mar;49(3):450-4.

7261.   Ruhl CE, Everhart JE.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003 Jan;124(1):71-9.

7262.   Sedlaczek N, Hasilik A, Neuhaus P, Schuppan D, Herbst H.  Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis. Br J Cancer. 2003 Mar 10;88(5):733-9.

7263.   Shehab TM, Orrego M, Chunduri R, Lok AS.  Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol. 2003 Mar;98(3):639-44.

7264.   Shim YH, Yoon GS, Choi HJ, Chung YH, Yu E.  p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. Cancer Lett. 2003 Feb 20;190(2):213-9.

7265.   Sorvillo F, Mazziotti G, Carbone A, Morisco F, Cioffi M, Rotondi M, Stornaiuolo G, Amato G, Gaeta GB, Caporaso N, Carella C.  Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. Clin Endocrinol (Oxf). 2003 Feb;58(2):207-12.

7266.   Van Thiel DH, George M, Brems J, Holt D, Zhu Q, Edelstein S, Amiral J, Tarasuk G, Leone N.  Antiphospholipid antibodies before and after liver transplantation. Am J Gastroenterol. 2003 Feb;98(2):460-5.

7267.   Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, de Franchis R.  High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol. 2003 Jan;38(1):50-4.

7268.   Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, Martinez I, Rodrigo L.  Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003 Mar;37(3):520-7.

7269.   Yuce A, Kocak N, Demir H, Gurakan F, Ozen H, Saltik IN, Ozcay F.  Evaluation of diagnostic parameters of Wilson's disease in childhood. Indian J Gastroenterol. 2003 Jan-Feb;22(1):4-6.

7270.   Zech B, Kurtenbach A, Krieger N, Strand D, Blencke S, Morbitzer M, Salassidis K, Cotten M, Wissing J, Obert S, Bartenschlager R, Herget T, Daub H.   Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol. 2003 Mar;84(Pt 3):555-60.


7271.   Gaud U, Langer B, Petropoulou T, Thomas HC, Karayiannis P.  Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. J Med Virol. 2003 Mar;69(3):350-6.

7272.   Geier A, Dietrich CG, Gartung C.  Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels. Hepatology. 2003 Mar;37(3):712-3

7273.   Hu Y, Shahidi A, Park S, Guilfoyle D, Hirshfield I.  Detection of extrahepatic hepatitis C virus replication by a novel, highly sensitive, single-tube nested polymerase chain reaction. Am J Clin Pathol. 2003 Jan;119(1):95-100.

7274.   Ma SP, Sakugawa H, Makino Y, Tadano M, Kinjo F, Saito A.   The complete genomic sequence of hepatitis delta virus genotype IIb prevalent in Okinawa, Japan. J Gen Virol. 2003 Feb;84(Pt 2):461-4.

7275.   Okamoto N, Yotsuyanagi H, Ooka S, Matsui T, Suzuki Kurokawa M, Suzuki M, Iino S, Nishioka K, Kato T.  Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapy. Intervirology. 2003;46(1):56-65.

7276.   Pasquier C, Bujan L, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, Massip P, Puel J, Izopet J.   Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol. 2003 Mar;69(3):344-9.

7277.   Santamaria E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, Corrales FJ.  Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3065-70.

7278.   Wong RH, Yeh CY, Hsueh YM, Wang JD, Lei YC, Cheng TJ.   Association of hepatitis virus infection, alcohol consumption and plasma vitamin A levels with urinary 8-hydroxydeoxyguanosine in chemical workers. Mutat Res. 2003 Mar 3;535(2):181-6.


7279.   Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ.  Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J. 2003 Feb;22(2):157-63.


7280.   Chen LK, Hwang SJ, Tsai ST, Luo JC, Lee SD, Chang FY.  Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol. 2003 Mar;9(3):505-8.

7281.   Gonzalez-Candelas F, Bracho MA, Moya A.  Molecular epidemiology and forensic genetics: application to a hepatitis C virus transmission event at a hemodialysis unit. J Infect Dis. 2003 Feb 1;187(3):352-8.

7282.   Ji X, Cheung R, Cooper S, Li Q, Greenberg HB, He XS.  Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology. 2003 Mar;37(3):610-21.

7283.   Kapadia SB, Brideau-Andersen A, Chisari FV.   Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2014-8.

7284.   Setchell KD, Heubi JE, Bove KE, O'Connell NC, Brewsaugh T, Steinberg SJ, Moser A, Squires RH Jr.   Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology. 2003 Jan;124(1):217-32.

October 2003

7965.      Abravaya K, Huff J, Marshall R, Merchant B, Mullen C, Schneider G, Robinson J. Molecular beacons as diagnostic tools: technology and applications. Clin Chem Lab Med. 2003 Apr;41(4):468-74. 

7966.      Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology. 2003 May;37(5):972-4. Review.

7967.      Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003 Jun;52(6):879-85.

7968.      Anzola M, Cuevas N, Lopez-Martinez M, Saiz A, Burgos JJ, de Pancorbo MM. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma. Cancer Lett. 2003 Apr 25;193(2):199-205.

7969.      Arndt T, Kuhn D, Herbst H, Linnemann M, Nikolaidis N. Increased carbohydrate-deficient transferrin of unknown etiology in a 15-year-old male patient with autoimmune hepatitis type 1. Clin Chem. 2003 Jun;49(6 Pt 1):1025-6.

7970.      Auroux J, Lamarque D, Roudot-Thoraval F, Deforges L, Chaumette MT, Richardet JP, Delchier JC. Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci. 2003 Jun;48(6):1118-23.

7971.      Ballot E, Bruneel A, Labas V, Johanet C. Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin Chem. 2003 Apr;49(4):634-43.

7972.      Berg T, Pascu M, Moller B. Prediction of spontaneous viral clearance in acute hepatitis C by viral load measurements. Hepatology. 2003 Jun;37(6):1495-6; author reply 1496.

7973.      Bolondi L. Screening tests for hepatocellular carcinoma. Hepatology. 2003 Jun;37(6):1493; author reply 1493.

7974.      Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, Lotterer E, Fleig W, Muller MJ. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr. 2003 May;77(5):1269-77.

7975.      Brunetti G, Delmastro M, Nava S, Pignatti P, Bossi A, Gatti M, Furione M. Detection of HCV-RNA in bronchoalveolar lavage from a woman with pulmonary fibrosis. Respir Med. 2003 Jun;97(6):736-8.

7976.      Burchell AN, Calzavara LM, Myers T, Schlossberg J, Millson M, Escobar M, Wallace E, Major C. Voluntary HIV testing among inmates: sociodemographic, behavioral risk, and attitudinal correlates. J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):534-41.

7977.      Cadranel JF, Di Martino V, Dorent R, Bernard B, Hoang C, Myara A, Pauwels A, Ghoussoub JJ, Perrin M, Grippon P, Thabut D, Trivin F, Huraux JM, Gandjbakhch I, Opolon P, Lunel F. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study. Transplantation. 2003 Apr 15;75(7):977-82.

7978.      Cengiz C, Akarca US, Goker E, Yuce G. Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters. Dig Dis Sci. 2003 May;48(5):865-9.

7979.      Chan MT, Gin T, Chui AK, Lau WY. Pitfalls of indocyanine green dye elimination to assess graft function during liver transplantation. Anesth Analg. 2003 Jun;96(6):1839-40; author reply 1840-1.

7980.      Erdtmann L, Franck N, Lerat H, Le Seyec J, Gilot D, Cannie I, Gripon P, Hibner U, Guguen-Guillouzo C. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem. 2003 May 16;278(20):18256-64. Epub 2003 Feb 20.

7981.      Gehrke SG, Riedel HD, Herrmann T, Hadaschik B, Bents K, Veltkamp C, Stremmel W. UbcH5A, a member of human E2 ubiquitin-conjugating enzymes, is closely related to SFT, a stimulator of iron transport, and is up-regulated in hereditary hemochromatosis. Blood. 2003 Apr 15;101(8):3288-93. Epub 2002 Dec 12.

7982.      Gelatti U, Donato F, Tagger A, Fantoni C, Portolani N, Ribero ML, Martelli C, Trevisi P, Covolo L, Simonati C, Nardi G; Brescia HCC Study. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol. 2003 Apr;98(4):907-14.

7983.      Golia P, Talal A. Editorial comment: diagnosis of acute HIV infection in hepatitis C treatment nonresponders--is extra vigilance required? AIDS Read. 2003 Jun;13(6):288-90.

7984.      Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis. 2003 Apr;30(4):340-4.

7985.      Hezode C, Lonjon I, Roudot-Thoraval F, Pawlotsky JM, Zafrani ES, Dhumeaux D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther. 2003 Apr15;17(8):1031-7.

7986.      Ho SK, Yam WC, Leung ET, Wong LP, Leung JK, Lai KN, Chan TM. Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. J Med Microbiol. 2003 May;52(Pt 5):397-402.

7987.      Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, Changchien CS, Lee CM, Tai MH. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer. 2003 Apr 15;97(8):1929-40.

7988.      James C, Trouette H, Marit G, Cony-Makhoul P, Mahon FX. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia. 2003 May;17(5):978-9.

7989.      Jeong SY, Kim KJ, Kim DJ, Oh SW, Choi EY. Sandwich ELISA for measurement of cytosolic aspartate aminotransferase in sera from patients with liver diseases. Clin Chem. 2003 May;49(5):826-9.

7990.      Kono Y, Hayashida K, Tanaka H, Ishibashi H, Harada M. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. J Med Virol. 2003 May;70(1):42-8.

7991.      Lohr HF, Pingel S, Weyer S, Fritz T, Galle PR. Individual and common antigen-recognition sites of liver-derived T cells in patients with autoimmune hepatitis. Scand J Immunol. 2003 Apr;57(4):384-90.

7992.      Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology. 2003 May;37(5):1114-21.

7993.      McKeown C, Thaker U, Cubitt WD, Novelli V. Retrospective screening for hepatitis C in a tertiary paediatric referral centre. Commun Dis Public Health. 2003 Apr;6(1):40-3.

7994.      Mommeja-Marin H, Mondou E, Blum MR, Rousseau F. Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology. 2003 Jun;37(6):1309-19. Review.

7995.      Nardacci R, Lo Iacono O, Ciccosanti F, Falasca L, Addesso M, Amendola A, Antonucci G, Craxi A, Fimia GM, Iadevaia V, Melino G, Ruco L, Tocci G, Ippolito G, Piacentini M.  Transglutaminase type II plays a protective role in hepatic injury. Am J Pathol. 2003 Apr;162(4):1293-303.

7996.      Nolte FS, Green AM, Fiebelkorn KR, Caliendo AM, Sturchio C, Grunwald A, Healy M. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5' noncoding region. J Clin Microbiol. 2003 Apr;41(4):1558-64.

7997.      Olga OZ, Nikolai DY. Invasive and non-invasive monitoring of hepatitis C virus-induced liver fibrosis: alternatives or complements? Curr Pharm Biotechnol. 2003 Jun;4(3):195-209. Review.

7998.      Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003 May 24;361(9371):1767-72.

7999.      Raghuraman S, Subramaniam T, Daniel D, Sridharan G, Abraham P. Occurrence of false positives during testing for antibodies to hepatitis C virus among volunteer blood donors in India. J Clin Microbiol. 2003 Apr;41(4):1788-90.

8000.      Riley NE, Li J, McPhaul LW, Bardag-Gorce F, Lue YH, French SW. Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp Mol Pathol. 2003 Apr;74(2):168-72.

8001.      Sadeyen JR, Tourne S, Shkreli M, Sizaret PY, Coursaget P. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope. Virology. 2003 Apr 25;309(1):32-40.

8002.      Serra JJ, Monte GU, Mello ES, Coral GP, Avila LF, Parga JR, Ramires JA, Rochitte CE. Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation. 2003 May 27;107(20):e188-9.

8003.      Soresi M, Bonfissuto G, Magliarisi C, Riili A, Terranova A, Di Giovanni G, Bascone F, Carroccio A, Tripi S, Montalto G. Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis. Clin Radiol. 2003 May;58(5):372-7.

8004.      Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T.  Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology. 2003 May;37(5):1220-1; author reply 1221.

8005.      Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C. Hepatology. 2003 May;37(5):1189-98.

8006.      Zanetti AR, Romano L, Brunetto M, Colombo M, Bellati G, Tackney C. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol. 2003 May;70(1):27-30.


8007.      Elazar M, Cheong KH, Liu P, Greenberg HB, Rice CM, Glenn JS. Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol. 2003 May;77(10):6055-61.

8008.      Huang YS, Chern HD, Su WJ, Wu JC, Chang SC, Chiang CH, Chang FY, Lee SD. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology. 2003 Apr;37(4):924-30.

8009.      Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP; Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion. 2003 Jun;43(6):696-704.

8010.      Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol. 2003 Apr;77(8):4781-93.

8011.      Ogata N, Ichida T, Aoyagi Y, Kitajima I. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity. Rinsho Byori. 2003 Apr;51(4):313-9.

8012.      Poljak M, Seme K, Marin IJ, Babic DZ, Matcic M, Meglic J. Frequency of the 32-base pair deletion in the chemokine receptor CCR5 gene is not increased in hepatitis C patients. Gastroenterology. 2003 May;124(5):1558-60; author reply 1560-1.

8013.      Ruhl CE, Everhart JE.  Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology. 2003 Jun;124(7):1821-9.

8014.      Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology. 2003 May;37(5):1180-8.


8015. Soroosh P, Shokri F, Azizi M, Jeddi-Tehrani M. Analysis of T-cell receptor beta chain variable gene segment usage in healthy dult responders and nonresponders to recombinant hepatitis B vaccine. cand J Immunol. 2003 May;57(5):423-31.


Click Here for Abstract

Back To Content Page